OECD says China will become R&D world number two in 2006

11 December 2006

The Organization for Economic Cooperation and Development has issued projections that indicate China will overtake Japan by the end of 2006 as the world's second largest R&D investor. The USA remains the clear global leader in this area with $330.0 billion R&D spending versus China's forecast $136.0 billion.

Since 1995, R&D spending as a percentage of Gross Domestic Product is estimated to have doubled to 1.2%, in a period when the economy has grown an average 9%-10% per year.

The OECD also calculates that Japan will spend $130.0 billion and the European Union's 15 members (before 2004 enlargement) $230.0 billion on R&D respectively.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight